zenocutuzumab
merus
['sclc', 'zenocutuzumab', 'nsclc']
the #oncoalerttoptweet day 3 #asco22 tweet nrg1 fusions are part of the #nsclc drivers family zenocutuzumab, a her2-her3 bispecific antibody, has significant activity in a nrg1+ tumor agnostic population best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??